Rapid-acting insulin approved for marketing.
D004334:Drug Administration Schedule; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D061268:Insulin Lispro
D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro